CWK
Cushman & Wakefield plc NYSE Listed Aug 2, 2018$13.84
Mkt Cap $3.2B
52w Low $9.43
55.3% of range
52w High $17.40
50d MA $13.22
200d MA $14.89
P/E (TTM)
37.1x
EV/EBITDA
14.3x
P/B
1.7x
Debt/Equity
1.7x
ROE
4.5%
P/FCF
12.8x
RSI (14)
—
ATR (14)
—
Beta
1.49
50d MA
$13.22
200d MA
$14.89
Avg Volume
2.1M
Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. The company operates through Americas; Europe, Middle East, and Africa; and Asia Pacific segments. It offers integrated facilities management, project and development, portfolio administration, transaction management, and strategic consulting services; property management services, including client accounting, engineering and operations, lease compliance administration, project and development, and sustainability services; and self-performed facilities services, which include janitorial, maintenance, critical environment management, landscaping, and office services. The company also provides owner representation and tenant representation leasing services; capital market services, including investment sales and equity, and debt and structured financing for real estate purchase and sales transactions; and appraisal management, investment management, valuation advisory, portfolio advisory, diligence advisory, dispute analysis and litigation support, financial reporting, and property and/or portfolio valuation services on real estate debt and equity decisions. Cushman & Wakefield has strategic partnerships with Vanke Service (Hong Kong) Co., Limited. It serves real estate owners and occupiers, such as tenants, investors, and multi-national corporations. Cushman & Wakefield plc was founded in 1784 and is based in London, the United Kingdom.
125 Old Broad Street · London EC2N 1AR · GB
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 14.46 | -1.5% | -4.2% | — | — | — | — | — |
| Feb 19, 2026 | AMC | 0.53 | -0.10 | -118.5% | 13.13 | -0.4% | +1.5% | -1.5% | +3.4% | +4.8% | +5.5% | — |
| Oct 30, 2025 | AMC | 0.28 | 0.29 | +3.6% | 16.18 | -1.2% | -3.0% | -3.7% | -3.4% | -4.2% | -4.7% | — |
| Aug 5, 2025 | AMC | 0.22 | 0.30 | +36.4% | 13.39 | +0.0% | +2.1% | +0.0% | +2.2% | +0.8% | +6.1% | — |
| Apr 29, 2025 | AMC | 0.02 | 0.09 | +350.0% | 9.41 | -1.6% | -0.4% | +2.0% | +7.1% | +6.4% | +4.6% | — |
| Feb 20, 2025 | AMC | 0.45 | 0.48 | +6.7% | 12.24 | +0.7% | -4.9% | -4.1% | -3.1% | -1.9% | -2.8% | — |
| Nov 4, 2024 | AMC | 0.20 | 0.23 | +15.0% | 13.14 | +5.0% | +15.4% | +11.3% | +13.2% | +13.5% | +14.8% | — |
| Jul 29, 2024 | AMC | 0.18 | 0.20 | +11.1% | 13.31 | -2.1% | -3.6% | -1.5% | -4.6% | -6.8% | -10.3% | — |
| Apr 29, 2024 | AMC | -0.06 | -0.13 | -100.0% | 9.91 | -2.9% | -2.6% | -3.0% | +0.0% | +1.1% | +2.1% | — |
| Feb 20, 2024 | AMC | 0.39 | 0.45 | +15.4% | 11.14 | +1.3% | -10.2% | -10.1% | -11.8% | -13.1% | -11.8% | — |
| Oct 30, 2023 | AMC | 0.20 | 0.21 | +5.0% | 6.78 | +2.4% | +8.7% | +10.6% | +12.7% | +21.8% | +19.5% | — |
| Jul 31, 2023 | AMC | 0.21 | 0.22 | +4.8% | 9.83 | +0.9% | +4.2% | +3.2% | +2.8% | +5.0% | +6.0% | — |
| May 4, 2023 | AMC | 0.19 | -0.04 | -121.1% | 8.94 | -0.4% | -10.7% | -15.5% | -14.2% | -12.2% | -13.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $11.89 | $12.04 | +1.3% | +2.1% | +4.0% | +4.9% | +4.2% | +2.0% |
| Nov 21 | Citigroup | Upgrade | Neutral → Buy | — | $14.74 | $15.39 | +4.4% | +8.6% | +9.2% | +13.8% | +14.5% | +13.6% |
| Nov 12 | Citigroup | Maintains | Neutral → Neutral | — | $15.93 | $16.37 | +2.8% | -0.1% | -2.5% | -2.8% | -7.3% | -7.2% |
| Nov 3 | Citizens | Maintains | Market Outperform → Market Outperform | — | $15.70 | $15.65 | -0.3% | -0.8% | -0.4% | -1.3% | -1.8% | +0.2% |
| Oct 10 | UBS | Maintains | Neutral → Neutral | — | $14.87 | $15.09 | +1.5% | -1.7% | +1.1% | +4.6% | +7.0% | +6.1% |
| Aug 26 | JP Morgan | Maintains | Neutral → Neutral | — | $15.99 | $16.00 | +0.1% | -0.9% | -0.2% | -0.9% | -1.4% | -3.6% |
| Aug 13 | Goldman Sachs | Maintains | Buy → Buy | — | $14.21 | $14.40 | +1.3% | +5.4% | +4.9% | +4.0% | +4.5% | +6.5% |
| Aug 8 | Goldman Sachs | Upgrade | Sell → Buy | — | $13.39 | $13.87 | +3.6% | +2.2% | +0.8% | +6.1% | +11.9% | +11.4% |
| Aug 6 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $13.39 | $13.39 | +0.0% | +2.1% | +0.0% | +2.2% | +0.8% | +6.1% |
| Jul 2 | UBS | Maintains | Neutral → Neutral | — | $11.39 | $11.47 | +0.7% | +2.3% | +4.0% | +1.8% | +0.5% | +0.8% |
| Jun 12 | Morgan Stanley | Maintains | Overweight → Overweight | — | $10.65 | $10.64 | -0.1% | +1.4% | -2.3% | -0.3% | -3.7% | -2.3% |
| Apr 24 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.52 | $8.52 | +0.0% | +5.2% | +3.3% | +5.8% | +10.4% | +10.0% |
| Apr 11 | UBS | Maintains | Neutral → Neutral | — | $7.99 | $7.84 | -1.9% | +0.9% | +3.5% | +3.1% | +2.0% | +3.6% |
| Apr 10 | JP Morgan | Maintains | Neutral → Neutral | — | $8.58 | $8.24 | -4.0% | -6.9% | -6.1% | -3.6% | -4.0% | -5.0% |
| Mar 19 | Goldman Sachs | Maintains | Sell → Sell | — | $10.46 | $10.51 | +0.5% | +0.4% | +1.1% | -0.2% | +3.2% | +1.9% |
| Mar 17 | Citigroup | Maintains | Neutral → Neutral | — | $10.69 | $10.55 | -1.3% | +0.3% | -2.2% | -1.8% | -1.1% | -2.3% |
| Feb 21 | Goldman Sachs | Maintains | Sell → Sell | — | $12.24 | $12.32 | +0.7% | -4.9% | -4.1% | -3.1% | -1.9% | -2.8% |
| Jan 2 | Jefferies | Downgrade | Buy → Hold | — | $13.08 | $13.10 | +0.2% | -3.7% | -2.0% | -1.8% | -6.0% | -6.8% |
| Dec 16 | JP Morgan | Maintains | Neutral → Neutral | — | $14.87 | $14.97 | +0.7% | +1.0% | -1.7% | -10.1% | -12.9% | -12.0% |
| Jul 30 | JP Morgan | Maintains | Neutral → Neutral | — | $13.31 | $13.03 | -2.1% | -3.6% | -1.5% | -4.6% | -6.8% | -10.3% |
| Jul 25 | Raymond James | Maintains | Outperform → Outperform | — | $12.44 | $12.60 | +1.3% | +5.9% | +8.8% | +7.0% | +3.1% | +5.4% |
| Jun 21 | JP Morgan | Maintains | Neutral → Neutral | — | $10.69 | $10.69 | +0.0% | +1.7% | -1.2% | -3.4% | -4.1% | -3.1% |
| Apr 9 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $10.98 | $10.79 | -1.7% | -3.4% | -7.7% | -9.8% | -10.0% | -12.8% |
| Apr 8 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $10.70 | $10.86 | +1.5% | +2.6% | -0.8% | -5.2% | -7.5% | -7.7% |
| Apr 3 | Raymond James | Downgrade | Strong Buy → Outperform | — | $10.07 | $9.77 | -3.0% | +1.5% | +2.4% | +6.3% | +9.0% | +5.4% |
| Jan 25 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $9.97 | $10.22 | +2.5% | +3.6% | +3.6% | +6.7% | +7.1% | +5.5% |
| Dec 8 | Wolfe Research | Upgrade | Peer Perform → Outperform | — | $8.61 | $8.79 | +2.1% | +3.3% | +3.4% | +2.6% | +12.4% | +23.2% |
| Nov 22 | UBS | Maintains | Neutral → Neutral | — | $8.40 | $8.53 | +1.5% | +0.6% | +1.8% | -0.1% | +1.8% | -1.0% |
| Oct 31 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $6.78 | $6.94 | +2.4% | +8.7% | +10.6% | +12.7% | +21.8% | +19.5% |
| Oct 4 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $6.84 | $6.80 | -0.6% | -0.7% | +2.3% | +4.8% | +7.3% | +11.3% |
| Sep 18 | Citigroup | Maintains | Neutral → Neutral | — | $8.27 | $8.22 | -0.6% | +0.6% | -1.0% | -2.8% | -10.8% | -8.7% |
| Aug 1 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $9.83 | $9.92 | +0.9% | +4.2% | +3.2% | +2.8% | +5.0% | +6.0% |
| Jul 24 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $9.95 | $9.96 | +0.1% | +0.9% | +1.1% | +3.2% | -4.4% | -3.0% |
| Jul 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.30 | $8.19 | -1.3% | +0.4% | -2.4% | +0.0% | +2.9% | +8.0% |
| Jun 28 | Citigroup | Maintains | Neutral → Neutral | — | $8.03 | $7.98 | -0.6% | -0.6% | +3.0% | +1.9% | +3.4% | +3.7% |
| May 19 | Credit Suisse | Maintains | Neutral → Neutral | — | $8.11 | $8.17 | +0.7% | -3.1% | +0.6% | +0.5% | -3.6% | -4.6% |
| May 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.55 | $7.40 | -2.0% | +1.6% | +4.0% | +2.8% | +0.7% | +2.0% |
| May 5 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $8.94 | $8.90 | -0.4% | -10.7% | -15.5% | -14.2% | -12.2% | -13.2% |
| Apr 17 | UBS | Downgrade | Buy → Neutral | — | $9.51 | $9.15 | -3.8% | -0.4% | -1.7% | -0.9% | +0.1% | +1.3% |
| Apr 11 | Goldman Sachs | Maintains | Neutral → Neutral | — | $9.60 | $9.60 | +0.0% | +1.4% | -0.2% | +0.8% | -0.9% | -1.4% |
| Apr 10 | Goldman Sachs | Downgrade | Buy → Neutral | — | $9.85 | $9.61 | -2.4% | -2.5% | -1.2% | -2.7% | -1.7% | -3.5% |
| Feb 1 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $14.43 | $14.12 | -2.1% | -1.7% | +4.2% | +4.2% | +1.4% | +2.2% |
| Jan 27 | Goldman Sachs | Maintains | Buy → Buy | — | $14.23 | $14.14 | -0.6% | +1.0% | -1.0% | +1.4% | -0.3% | +5.7% |
| Jan 20 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $13.75 | $13.80 | +0.4% | +2.3% | +3.5% | +1.9% | +1.4% | +3.5% |
| Nov 8 | Goldman Sachs | Maintains | Buy → Buy | — | $10.78 | $10.68 | -0.9% | -2.4% | -3.8% | +5.1% | +11.4% | +5.7% |
| Nov 4 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $10.60 | $10.04 | -5.3% | -0.1% | +1.7% | -0.8% | -2.2% | +6.9% |
| Oct 20 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $11.16 | $11.14 | -0.2% | -0.8% | +3.0% | +2.1% | +5.0% | +7.5% |
| Oct 19 | Goldman Sachs | Maintains | Buy → Buy | — | $11.86 | $11.57 | -2.4% | -5.9% | -6.7% | -3.1% | -4.0% | -1.2% |
| Jul 22 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $16.03 | $16.01 | -0.1% | -0.4% | -0.6% | -1.2% | +1.6% | +4.9% |
| Jul 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $15.79 | $15.65 | -0.9% | -5.6% | -4.0% | -4.2% | -4.4% | -3.5% |
No insider trades available.
8-K · 2.02
!! High
Cushman & Wakefield plc -- 8-K 2.02: Earnings Results
Cushman & Wakefield reported quarterly earnings results, with the detailed financial performance available in the attached press release exhibit.
May 7
8-K · 8.01
!! High
Cushman & Wakefield plc -- 8-K 8.01: Material Event / Announcement
Cushman & Wakefield is redeeming $100 million of its $650 million outstanding 6.750% senior secured notes due 2028, reducing debt obligations ahead of maturity.
May 4
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
CWK disclosed material information via Regulation FD that won't be integrated into formal SEC filings, limiting its legal binding effect and potentially signaling management's preference to control narrative distribution to investors.
Apr 8
8-K · 7.01
! Medium
Cushman & Wakefield Ltd. -- 8-K 7.01: Regulation FD Disclosure
Cushman & Wakefield will host an investor webcast on February 19, 2026, to discuss Q4 and full-year 2025 results with an accompanying presentation.
Feb 19
Data updated apr 25, 2026 4:19am
· Source: massive.com